BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4709108)

  • 21. Comparative tests for diagnosis of lead poisoning.
    Morgan JM; Burch HB
    Arch Intern Med; 1972 Sep; 130(3):335-40. PubMed ID: 4626703
    [No Abstract]   [Full Text] [Related]  

  • 22. [Combined action of penicillin, levomycetin and some water-soluble vitamins on aseptic inflammation and phagocytosis].
    Chukichev EM
    Antibiotiki; 1966 May; 11(5):442-6. PubMed ID: 4230734
    [No Abstract]   [Full Text] [Related]  

  • 23. [Experimental studies on the effects of various vitamins on blood sugar in rats and the mechanism of action].
    Machii B
    Nihon Naibunpi Gakkai Zasshi; 1966 May; 42(2):167-85. PubMed ID: 4226020
    [No Abstract]   [Full Text] [Related]  

  • 24. Laboratory diagnosis of increased lead absorption.
    Baloh RW
    Arch Environ Health; 1974 Apr; 28(4):198-208. PubMed ID: 4205503
    [No Abstract]   [Full Text] [Related]  

  • 25. Lead poisoning. A comprehensive review and report of a case.
    Gordon NC; Brown S; Khosla VM; Hansen LS
    Oral Surg Oral Med Oral Pathol; 1979 Jun; 47(6):500-12. PubMed ID: 108646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Nipiopharmacology of vitamins].
    Scano V; Garau A
    Minerva Nipiol; 1967; 17(6):325-63. PubMed ID: 4240934
    [No Abstract]   [Full Text] [Related]  

  • 27. The juvenile baboon as a model for studies of lead poisoning in children.
    Cohen N; Kneip TJ; Goldstein DH; Muchmore EA
    J Med Primatol; 1972; 1(3):142-55. PubMed ID: 4633129
    [No Abstract]   [Full Text] [Related]  

  • 28. [Porphyrin metabolism in endemic nephropathy and in persons in danger of lead poisoning].
    Iwanow ED
    Munch Med Wochenschr; 1968 Aug; 110(31):1783-9. PubMed ID: 5755403
    [No Abstract]   [Full Text] [Related]  

  • 29. Porphyrin biosynthesis. 3. Porphyrin metabolism in experimental lead poisoning.
    Kreimer-Birnbaum M; Grinstein M
    Biochim Biophys Acta; 1965 Nov; 111(1):110-23. PubMed ID: 5867314
    [No Abstract]   [Full Text] [Related]  

  • 30. [Biochemical study of various occupational groups exposed to lead].
    Kutter D; Machoud M
    Bull Soc Sci Med Grand Duche Luxemb; 1978; 115(1):35-41. PubMed ID: 699239
    [No Abstract]   [Full Text] [Related]  

  • 31. Dose-response to lead ingestion in rats fed low dietary calcium.
    Mahaffey KR; Goyer R; Haseman JK
    J Lab Clin Med; 1973 Jul; 82(1):92-100. PubMed ID: 4352267
    [No Abstract]   [Full Text] [Related]  

  • 32. Excretion of delta-aminolevulinic acid in the absence of demonstrable erythropoiesis.
    Shahidi NT; Efron ML
    Proc Soc Exp Biol Med; 1968 May; 128(1):314-7. PubMed ID: 5656709
    [No Abstract]   [Full Text] [Related]  

  • 33. [Urinary porphyrin pattern in lead poisoning].
    Schmidt D; Stich W
    Dtsch Med Wochenschr; 1972 Aug; 97(32):1176-80. PubMed ID: 5044648
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of sustained release versus regular multivitamin supplement upon vitamin C state.
    Richards TW; Cheraskin E; Ringsdorf WM
    Int Z Vitaminforsch; 1969; 39(4):407-15. PubMed ID: 4244965
    [No Abstract]   [Full Text] [Related]  

  • 35. Urinary excretion of 5-hydroxyindoleacetic acid, delta-aminolevulinic acid and coproporphyrin isomers in rats and men exposed to lead.
    Ichiba M; Tomokuni K
    Toxicol Lett; 1987 Sep; 38(1-2):91-6. PubMed ID: 2442858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Behavior of deltaaminolevulinic acid concentration in urine and various hematologic parameters in lead-exposed subjects].
    Heinemann G
    Zentralbl Arbeitsmed Arbeitsschutz Prophyl; 1980 Mar; 30(3):70-4. PubMed ID: 7467900
    [No Abstract]   [Full Text] [Related]  

  • 37. Lead induced disorders in hematopoietic and drug metabolizing enzyme system and their protection by ascorbic acid supplementation.
    Vij AG; Satija NK; Flora SJ
    Biomed Environ Sci; 1998 Mar; 11(1):7-14. PubMed ID: 9559098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A study of vitamin inhibition on the mutagenicity of the antineoplastic drugs].
    Zhao ZZ; Huang MT
    Zhonghua Yu Fang Yi Xue Za Zhi; 1992 Sep; 26(5):291-3. PubMed ID: 1298607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Porphyrin--how to read its figures].
    Takaku F
    Nihon Rinsho; 1971 Jan; 29():Suppl:326-36. PubMed ID: 4928276
    [No Abstract]   [Full Text] [Related]  

  • 40. [Disorders of heme synthesis during anemia and chronic liver diseases].
    Sroczynski J; Urbanowicz H; Strynk M
    Sem Hop; 1968 Nov; 44(46):2819-26. PubMed ID: 4311293
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.